EBV(+) DLBCL exhibited a significant predominance of cytotoxic CD8(+) T-cells relative to EBV(−) DLBCL (p = 0.01), as well as a relative predominance in neutrophils, monocytes, and NK cells comprising the background inflammatory microenvironment. The gene discussed is CD8A; the disease is diffuse large B-cell lymphoma.